Cargando…
Adverse events of antibody–drug conjugates on the ocular surface in cancer therapy
Antibody–drug conjugates consist of a monoclonal antibody attached to a cytotoxic therapeutic molecule by a connector. This association allows a highly specific therapy, which increases their effectiveness and decreases their potential toxicity. This new therapy emerged approximately 20 years ago; s...
Autores principales: | Domínguez-Llamas, Sandra, Caro-Magdaleno, Manuel, Mataix-Albert, Beatriz, Avilés-Prieto, Javier, Romero-Barranca, Isabel, Rodríguez-de-la-Rúa, Enrique |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10514170/ https://www.ncbi.nlm.nih.gov/pubmed/37454027 http://dx.doi.org/10.1007/s12094-023-03261-y |
Ejemplares similares
-
Keratograph 5M As A Useful And Objective Tool For Evaluating The Ocular Surface In Limbal Stem Cell Deficiency
por: Alfaro-Juárez, Asunción, et al.
Publicado: (2019) -
Ocular adverse events with immune checkpoint inhibitors
por: Fang, Tony, et al.
Publicado: (2019) -
Retrospective analysis of ocular adverse events with Clobetasol
por: Wang, Yu, et al.
Publicado: (2022) -
Complications and adverse events of plaque brachytherapy for ocular melanoma
por: Peddada, Krishi V., et al.
Publicado: (2019) -
Adverse Ocular Events following COVID-19 Vaccination
por: Eleiwa, Taher K., et al.
Publicado: (2021)